Haemonetics (HAE) Inventory Average (2010 - 2026)

Haemonetics' Inventory Average history runs 17 years deep, the most recent figure standing at $313.8 million for Q1 2026.

• On a quarterly basis, Inventory Average rose 85.26% year-over-year to $313.8 million in Q1 2026; TTM through Mar 2026 was $313.8 million, a 85.26% increase from a year earlier, with the FY2026 full-year figure at $335.8 million, down 1.59% from the prior year.
• Inventory Average slipped to $313.8 million in Q1 2026 per HAE's latest filing, from $328.7 million in the prior quarter.
• Across five years, Inventory Average topped out at $377.9 million in Q3 2024 and bottomed at $169.4 million in Q1 2025.
• The 5-year median for Inventory Average is $297.2 million (2022), against an average of $292.8 million.
• Across the five-year window, Inventory Average slumped 45.47% in 2025 and surged 85.26% in 2026, its largest moves.
• Year by year, Inventory Average stood at $255.2 million in 2022, then gained by 15.56% to $294.9 million in 2023, then plunged by 39.7% to $177.9 million in 2024, then surged by 84.81% to $328.7 million in 2025, then fell by 4.54% to $313.8 million in 2026.
• Per Business Quant, the three latest HAE Inventory Average figures stand at $313.8 million (Q1 2026), $328.7 million (Q4 2025), and $348.4 million (Q3 2025).